Press release
Pharmacogenomics Market Global Share, Trends, Business Boosting Strategies, Revenue and Forecast 2024-2031 | Abbott Laboratories, Agilent Technologies Inc, Becton.
Pharmacogenomics Market || 2024-2031
DataM Intelligence has published a new research report on "Pharmacogenomics Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. . The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/pharmacogenomics-market
The Pharmacogenomics market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
The Pharmacogenomics Market focuses on the study of how an individual's genetic makeup affects their response to drugs. By integrating pharmacology and genomics, this field aims to develop tailored medication strategies that maximize efficacy and minimize adverse effects, leading to more personalized healthcare solutions.
Key Developments:
On July 25, 2023, Illumina Inc. announced a collaboration with Pillar Biosciences Inc. aimed at enhancing Illumina's portfolio by integrating Pillar's oncology assays. This partnership seeks to expand the range of sequencing options available, making cancer testing more efficient, accurate, and cost-effective, ultimately improving access to personalized cancer treatments.
Earlier, on May 9, 2023, Pfizer and Thermo Fisher Scientific joined forces to enhance personalized cancer care for patients in international markets. Their partnership aims to provide access to next-generation sequencing-based testing in over 30 countries where affordable advanced genetic testing is limited or unavailable. The agreement focuses on increasing the availability of localized advanced testing capabilities, particularly for breast and lung cancer patients.
Forecast Growth Projected:
The Global Pharmacogenomics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Pharmacogenomics Market:
Abbott Laboratories, Agilent Technologies Inc, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc, Illumine, Eurofins Scientific, Pacific Biosciences of California Inc, Qiagen and Thermo Fisher Scientific Inc among others.
Segment Covered in the Pharmacogenomics Market:
By Type: Products, Services.
By Technology: DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Other Technologies.
By Application: Drug Discovery, Neurology, Oncology, Pain Management, Other Applications, Software, Others.
By End-User: Hospitals, Specialty Clinics, Academic and Research Institutes, Pharmaceutical Companies, Others.
Regional Analysis:
The global Pharmacogenomics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pharmacogenomics-market
Regional Analysis:
The global Pharmacogenomics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Pharmacogenomics Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Pharmacogenomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Pharmacogenomics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/pharmacogenomics-market
The research study aims to address the following key questions:
➡What is the expected growth rate of the Pharmacogenomics Market during the forecast period of 2031?
➡What key factors are driving the Pharmacogenomics Market across various regions?
➡Who are the leading vendors in the Pharmacogenomics industry, and what strategies contribute to their success?
➡What is the anticipated market scope for the projected period?
➡What major trends are influencing the industry's growth in the coming years?
➡What challenges does the Pharmacogenomics Market face?
Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Global Share, Trends, Business Boosting Strategies, Revenue and Forecast 2024-2031 | Abbott Laboratories, Agilent Technologies Inc, Becton. here
News-ID: 3668484 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Agricultural Micronutrients Market Set for Robust Growth as Farmer …
Market Size and Growth:
The Global Agricultural Micronutrients Market size reached USD 9,706 million in 2022 and is projected to witness lucrative growth by reaching up to USD 19,197 million by 2031. The market is expected to exhibit a CAGR of 9% during the forecast period (2024-2031).
The Agricultural Micronutrients Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth…
United States Telemedicine Market Set for Explosive Growth as Virtual Healthcare …
Market Size and Growth:
The Global Telemedicine Market size reached US$129.70 billion in 2024 and is expected to reach US$488.89 billion by 2033, growing at a CAGR of 16.8% during the forecast period 2025-2033
The Telemedicine Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these…
United States Clinical Trial Management System Market Set for Robust Growth with …
Market Size and Growth:
The Global Clinical Trial Management System Market size reached USD 1.5 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global clinical trial management system market is expected to exhibit a CAGR of 14.6% during the forecast period (2024-2031).
The Clinical Trial Management System Market report by DataM Intelligence provides insights into the latest trends and developments…
United States Healthcare Chatbots Market Set for Robust Growth as AI-Driven Pati …
Market Size and Growth:
The Healthcare Chatbots Market size reached US$ 823.96 Million in 2024 and is expected to reach US$ 5,692.97 Million by 2033, growing at a CAGR of 22.9% during the forecast period 2025-2033.
The Healthcare Chatbots Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
